SANTA CLARA, Calif. – Agilent Technologies, Inc. (NYSE: A) today announced that NIMGenetics S.L. of Madrid has achieved Certified Service Provider (CSP) status for genomic research using Agilent SurePrint comparative genomic hybridization (CGH) and CGH/SNP microarrays. “We are very proud to become the first Agilent CSP in Spain,” said Dr. Juan Cruz Cigudosa, NIMGenetics chief […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today announced the availability of multiple genomic microarray tools that will further enable scientists in the applied research field. The company is updating, developing, and manufacturing organism arrays in collaboration with leading scientific communities so that researchers in areas such as animal breeding, crop science, and microbial genetics […]
Houston, TX – The public miRBase sequence database serves as the primary probe content for many commercially available miRNA profiling microarrays. However, the continued updating of the database can be problematic for researchers using pre-made microarrays as the probe content of the arrays immediately goes out of date whenever a new miRBase version is released. […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip® Microarray Instrument System for in vitro diagnostic (IVD) use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic […]
MADISON, Wis. – Gentel Biosciences, a leader in proteomics profiling tools, announces today the introduction and use of the SilverQuant trademark for its protein array technology platform. Gentel acquired the SilverQuant trademark from Eppendorf AG, Hamburg Germany for worldwide commercial use. The acquisition was completed on March 31, 2011. According to Dan Clutter, Gentel’s Vice […]
MADISON, Wis. – Roche NimbleGen, a Roche (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) Company announced today that the Netherlands-based genomic service provider BaseClear BV has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. BaseClear has been certified to process customer samples using the NimbleGen SeqCap EZ Library (solution phase) workflow for next-generation sequencing, most specifically using SeqCap […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations. The researchers will use the microarrays over three years to study gene-expression profiles of […]
Dortmund – Protagen AG today announced that Scienion AG will produce protein microarray batches for the clinical validation of the proprietary biomarker panels of Protagen. The batch sizes will comprise more than 1000 arrays. Additionally, both companies plan to jointly evaluate new platforms for multiplex analytics and to co-develop novel approaches up to proof-of concept […]
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for NimbleGen Comparative Genomic Hybridization (CGH), Chromatin Immunoprecipiation-on-chip (ChIP-chip), DNA Methylation and Gene Expression. The addition of these applications means Ambry Genetics is now certified on all Roche […]
SANTA CLARA, Calif. – Agilent Technologies, Inc. (NYSE: A) today announced the availability of custom kits for its SureSelect XT target enrichment system that can capture up to 34 Mb of genomic regions of interest for next-generation sequencing (NGS). This fivefold increase in coverage from previous custom kits enables researchers to expand the breadth of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
